These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8554413)

  • 21. Chemotherapy and medical treatment of hepatocellular carcinoma (HCC).
    Rougier P; Mitry E; Clavero-Fabri MC
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1264-6. PubMed ID: 9730386
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical endocrinology and metabolism. Gut endocrine tumours.
    de Herder WW; Lamberts SW
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):477-95. PubMed ID: 15533771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current world literature.
    Curr Opin Urol; 2013 Jul; 23(4):377-88. PubMed ID: 23735869
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast radiotherapy after lumpectomy--no longer always necessary.
    Smith IE; Ross GM
    N Engl J Med; 2004 Sep; 351(10):1021-3. PubMed ID: 15342811
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of prostate cancer].
    Romics I
    Orv Hetil; 2010 Apr; 151(14):580-3. PubMed ID: 20332076
    [No Abstract]   [Full Text] [Related]  

  • 26. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract]   [Full Text] [Related]  

  • 27. Gastrointestinal regulatory peptides.
    Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):45-6. PubMed ID: 19104237
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues.
    Thomas RP; Hellmich MR; Townsend CM; Evers BM
    Endocr Rev; 2003 Oct; 24(5):571-99. PubMed ID: 14570743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined treatment of metastatic hormone-resistant prostate cancer].
    Kaprin AD; Gafanov RA; Al'bitskiĭ IA; Fastovets SV
    Vopr Onkol; 2009; 55(4):477-9. PubMed ID: 19947375
    [No Abstract]   [Full Text] [Related]  

  • 30. What is the pathophysiology of a hormone-resistant prostate tumour?
    Tombal B
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S179-88. PubMed ID: 21943973
    [No Abstract]   [Full Text] [Related]  

  • 31. Ovarian suppression in the management of premenopausal breast cancer: methods and efficacy in adjuvant and metastatic settings.
    McDonald Wade S; Hackney MH; Khatcheressian J; Lyckholm LJ
    Oncology; 2008; 75(3-4):192-202. PubMed ID: 18841034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgical or medical castration with LH-RH analogue for prostatic cancer].
    Kameyama S; Yamazaki S; Kitamura T
    Nihon Rinsho; 1998 Aug; 56(8):2114-8. PubMed ID: 9750518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gastrointestinal hormones--clinical significance].
    Duris I
    Vnitr Lek; 1989 Mar; 35(3):226-9. PubMed ID: 2734995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral control of gut function.
    Thompson JC
    Am J Surg; 1991 Jan; 161(1):6-18. PubMed ID: 1987858
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer.
    Bodmer A; Castiglione-Gertsch M
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S28-37. PubMed ID: 21943985
    [No Abstract]   [Full Text] [Related]  

  • 36. New directions in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): shifting from symptom management to targeting tumors.
    Weber M
    Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):12-7. PubMed ID: 25768104
    [No Abstract]   [Full Text] [Related]  

  • 37. Words of wisdom: Re: High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: results of a phase III randomized study [abstract 3].
    Bolla M
    Eur Urol; 2013 Sep; 64(3):513. PubMed ID: 23915463
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on extended adjuvant therapy options in breast cancer.
    ONS News; 2004; 19(9 Suppl):51-2. PubMed ID: 15478586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprevention of breast cancer.
    O'Shaughnessy JA
    JAMA; 1996 May; 275(17):1349-53. PubMed ID: 8614122
    [No Abstract]   [Full Text] [Related]  

  • 40. [Digestive hormones].
    Monés J; Farré A; Calabuig R; Clavé P; Lluis F
    Rev Esp Enferm Dig; 1993 Sep; 84(3):178-94. PubMed ID: 8217384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.